主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GH
#3250
Guardant Health, Inc. - Common Stock
1.3
0
USD
-99.03%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-99.03%
每月变动
-98.46%
6个月变化
-98.80%
年变化
-98.21%
前一天收盘价
133.2
2
Open
1.3
0
最低价
1.3
0
High
1.3
0
交易量
274
市场
US Stock Market
医疗保健
GH
展开完整图表
完整图表
Financials
概览
声明
统计
每季度
年度
利润表
资产负债表
现金流
值
2020
2021
2022
2023
2024
2025
TTM
经营活动产生的现金
-103.93 M
-209.02 M
-309.46 M
-324.98 M
-239.86 M
-184.76 M
-187.69 M
投资活动产生的现金
-617.09 M
-63.16 M
149.82 M
840.25 M
-261.31 M
-627.2 M
-230.65 M
融资活动产生的现金
1.41 B
-66.82 M
-189.09 M
477.38 M
-996 K
671.13 M
716.41 M
自由现金流
-103.93 M
-209.02 M
-309.46 M
-324.98 M
-239.86 M
-233.07 M
-237.12 M
Guardant Health, Inc. - Common Stock
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
新闻
Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings
Baron Health Care Fund Q1 2026 Portfolio Activity
Guardant Health Just Broke Out On Bullish News For Its Colon Cancer-Detecting Blood Test
Dow Jones Futures Fall After Strong Nvidia Earnings; SpaceX Files For Huge IPO
Guardant Health Leaps On A Major Win In Cancer Detection; Will Shares Break Out?
Guardant Health: Reveal And Shield Driving The Next Growth Phase (NASDAQ:GH)
The Cancer Test That Wall Street Is Betting On
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)
Guardant Health, Inc. (GH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates
Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates